Pericardial fluid - Dispensable or indispensable fluid and an example of patentable bio-diversity

International Journal of Cardiology

Volumn 77, Issue 2-3, 2001, Pages 109-111

  Coats, A J S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NEUROHORMONE; NEUROTRANSMITTER;

BIODIVERSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CORONARY ARTERY BLOOD FLOW; CYTOKINE RELEASE; EDITORIAL; GENE THERAPY; HEART MUSCLE; PERICARDIAL EFFUSION; PRIORITY JOURNAL;

EID: 0035131705     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00369-2     Document Type: Article

References (27)

1. Pericardial fluid as a new material for clinical heart research
2. The importance and complexity of neurohumeral overactivity in chronic heart failure
3. Plasma cytokine parameters and mortality in patients with chronic heart failure
4. The activated immune system in congestive heart failure - From dropsy to the cytokine paradigm
5. Paracrine modulation of heart cell function by endothelial cells
6. Potential paracrine role of the pericardium in the regulation of cardiac function
7. Left ventricular remodelling: Common process in patients with different primary myocardial disorders
8. Pericardial fluid from patients with ischemic heart disease accelerates the growth of human vascular smooth muscle cells
9. Pericardial fluid from patients with unstable angina induces vascular endothelial cell apoptosis
10. Microphysiology of the pericardium in relation to intrapericardial therapeutics and diagnostics
11. Preclinical safety testing of percutaneous transatrial access to the normal pericardial space for local cardiac drug delivery and diagnostic sampling
12. Myocardial revascularisation: The search for the holy grail
13. A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid
14. Catecholamines in pericardial fluid of normotensive, spontaneously hypertensive and reserpine-treated rats
15. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction
16. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure
17. Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease
18. Presence of immunoreactive endothelin-1 and atrial natriuretic peptide in human pericardial fluid
19. Enhanced accumulation of pericardial fluid adenosine and inosine in patients with coronary artery disease
20. Detection of mRNA encoding H(1) receptor and iNOS by RT-PCR in autoimmune myocarditis with special reference to changes in heart contractility
21. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction
22. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat
23. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model
24. Establishment of a clinically correlated human pericardial fluid bank: Evaluation of intrapericardial diagnostic potential
25. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy
26. Pharmacogenomics: Hope or hype?
27. Consumer involvement in cardiovascular research: Ways to combat bias and secrecy